Clinical

Dataset Information

Stem Cell Transplantation in Treating Patients With Hematologic Cancer


ABSTRACT: RATIONALE: Peripheral stem cell transplantation may be able to replace immune cells that were destroyed by chemotherapy and radiation therapy used to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of treated donor stem cell transplantation in treating patients who have hematologic cancer.

DISEASE(S): Myelodysplastic Syndromes,Extramedullary Plasmacytoma,Myeloproliferative Disorders,Leukemia,Preleukemia,Multiple Myeloma And Plasma Cell Neoplasm,Graft Versus Host Disease,Small Intestine Cancer,Lymphoma,Monoclonal Gammopathy Of Undetermined Significance,Plasmacytoma,Graft Vs Host Disease,Precancerous Conditions,Intestinal Neoplasms,Precancerous/nonmalignant Condition,Neoplasms, Plasma Cell,Multiple Myeloma,Chronic Myeloproliferative Disorders

PROVIDER: 2004049 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR